SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-031363
Filing Date
2023-08-31
Accepted
2023-08-31 17:27:39
Documents
14
Period of Report
2023-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45134
2 ex10-1.htm EX-10.1 17436
3 ex10-2.htm EX-10.2 17683
  Complete submission text file 0001493152-23-031363.txt   267646

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mira-20230828.xsd EX-101.SCH 3048
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mira-20230828_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mira-20230828_pre.xml EX-101.PRE 22811
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3576
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 231229835
SIC: 2834 Pharmaceutical Preparations